
Hologic Inc
NASDAQ:HOLX

Intrinsic Value
The intrinsic value of one
HOLX
stock under the Base Case scenario is
76.55
USD.
Compared to the current market price of 61.32 USD,
Hologic Inc
is
Undervalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Hologic Inc
Fundamental Analysis

Hologic’s heavy reliance on its top-tier diagnostic tests and imaging systems leaves it exposed to reimbursement rate fluctuations. If governmental or private payers reduce reimbursements for breast health procedures or molecular tests, the company’s revenue and margins could face significant pressure.
Hologic’s leading position in breast health and molecular diagnostics provides a strong competitive moat, especially as demand for precise cancer screenings grows globally. Its well-established distribution networks and reputable brand name help the firm maintain pricing power and customer loyalty.

Revenue & Expenses Breakdown
Hologic Inc
Balance Sheet Decomposition
Hologic Inc
Current Assets | 3.5B |
Cash & Short-Term Investments | 2B |
Receivables | 631.4m |
Other Current Assets | 889.5m |
Non-Current Assets | 5.2B |
Long-Term Investments | 47.9m |
PP&E | 537.2m |
Intangibles | 4.2B |
Other Non-Current Assets | 433.8m |
Free Cash Flow Analysis
Hologic Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Hologic Inc
Revenue
|
4B
USD
|
Cost of Revenue
|
-1.8B
USD
|
Gross Profit
|
2.3B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
995.9m
USD
|
Other Expenses
|
-251.9m
USD
|
Net Income
|
744m
USD
|
HOLX Profitability Score
Profitability Due Diligence
Hologic Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Score
Hologic Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
HOLX Solvency Score
Solvency Due Diligence
Hologic Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Score
Hologic Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HOLX Price Targets Summary
Hologic Inc
According to Wall Street analysts, the average 1-year price target for
HOLX
is 81.16 USD
with a low forecast of 70.7 USD and a high forecast of 94.5 USD.
Dividends
Current shareholder yield for HOLX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HOLX
stock under the Base Case scenario is
76.55
USD.
Compared to the current market price of 61.32 USD,
Hologic Inc
is
Undervalued by 20%.